Pliant Therapeutics Appoints David Raben as Chief Medical Officer

Pliant Therapeutics appointed David Raben, M.D., as Chief Medical Officer and granted him options for 575,000 shares vesting over four years. This move is intended to strengthen execution of Pliant’s oncology pipeline.